Recent advances in the pathophysiology of Musculocontractural Ehlers-Danlos syndrome
And small peptide GLP-1 analogues have been demonstrated to cross BBB via peripheral administration, including LG, lixisenatide and exendin-4 (72)
GLP-1 receptor agonists (GLP-1 RAs) are medications designed to mimic that natural hormone but with a longer-lasting effect
In 2021, it became the first drug (marketed under the brand name Wegovy) since 2014s Saxenda approved for chronic weight management in the 70% of American adults who are overweight or obese
Side effects include: acne, blood clots, aggressiveness, hallucinations, mania, stomach pain, headaches, dizziness, high blood pressure, testicular or scrotal pain, premature male baldness, hear attack, stroke, and liver or kidney failure